MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2024 International Congress

    TRPV1: A Potential Therapeutic Target for Inflammation and Pain in Parkinson’s Disease

    SJ. Song, YE. Kim (Anyang, Republic of Korea)

    Objective: Unveiling the Pain Mechanism in Parkinson's Disease: A Path to New Therapies Background: Parkinson's disease (PD) are well-known movement disorder. While motor symptoms are…
  • 2024 International Congress

    Combining MDS-UPDRS Parts 1 and 2: using the patient’s voice

    C. Goetz, H. Zou, G. Stebbins, A. Schrag, T. Mestre, S. Luo (Chicago, USA)

    Objective: To test whether the patient-derived MDS-UPDRS Parts assessing non-motor (Part 1) and motor (Part 2) functional impact of PD can be summed to render…
  • 2024 International Congress

    Breaking Barriers to Offer Evidence-Based Services for Patients with Parkinson’s Disease in South Africa

    S. Govender, S. Haffejee (Johannesburg, South Africa)

    Objective: To provide evidence-based services for patients with Parkinson’s disease considering the burden of disease in South Africa (SA) and access, socio economic and technology…
  • 2024 International Congress

    An Analysis of Baseline Measures from a Diverse Parkinson’s Disease Interdisciplinary Clinic

    V. Armengol, M. Feldman, M. Sarno, S. Marmol, A. Alfonso, G. Dumenigo, M. Garcia-Casals, S. Munzesheimer, A. Otto, TW. Siu, D. Yacinthe, D. Shpiner (Miami, USA)

    Objective: To analyze differences in baseline characteristics of patients at a new diverse, academic Parkinson’s Disease (PD) interdisciplinary clinic (IDC). Background: The University of Miami…
  • 2024 International Congress

    Case Report: Carbamazepine-Induced Dystonia, Tremor and Negative Myoclonus

    D. Ouhabi, H. Naciri Darai, H. Tibar, W. Regragui (Rabat, Morocco)

    Objective: The objective of this case presentation is mainly to raise awareness of possible side effects of Carbamazepine in epileptic and non-epileptic patients, even years…
  • 2024 International Congress

    Baseline NSD-ISS stage predicts long term progression and survival in sporadic PD: 10-year PPMI data analysis

    P. Gonzalez-Latapi, C. Gochanour, H. Cho, S. Ho Choi, C. Caspell, C. Coffey, M. Brumm, Y. Xiao, DE. Lafontant, C. Venuto, C. Tanner, K. Kieburtz, L. Chahine, A. Siderowf, K. Marek, T. Simuni (Chicago, USA)

    Objective: To analyze long term progression in Neuronal Synuclein Disease (NSD) participants who were originally enrolled in the sporadic Parkinson Disease (sPD) cohort in PPMI…
  • 2024 International Congress

    Molecular Landscape of Gastrointestinal Dysfunctions in Parkinson’s Disease

    M. Lai, S. Kulkarni, B. Benitez (Boston, USA)

    Objective: Analyze multi-omics data from the PPMI cohort to identify molecular markers associated with self-reported gastrointestinal (GI) dysfunction in Parkinson's disease (PD) patients. Background: PD…
  • 2024 International Congress

    Assessing Barriers to Advance Care Planning in Parkinson’s Disease Within a Cuban-American Population

    T. Peabody, M. Abou-Ezzi, L. Hernandez, H. Moore, S. Vargas-Parra, A. Cruz, D. Shpiner (Miami, USA)

    Objective: Determine attitudes toward advance care planning among Cuban-American people with Parkinson’s disease (PWP). Background: Advance care planning (ACP) is a process that allows individuals…
  • 2024 International Congress

    Parkinson’s Disease Clinical Subtypes Differ in Health-Related QOL

    E. Carr, T. Cash, C. Lessov-Schlaggar, H. Hwang, A. Eid, P. Kotzbauer, J. Perlmutter, M. Campbell (St. Louis, USA)

    Objective: To determine whether clinical subtypes of Parkinson disease (PD) differ in health-related quality of life (QOL). Background: Health-related QOL varies for individuals with PD.…
  • 2024 International Congress

    Patient Reported Outcomes of Using a Chaplain Service in a Huntington’s Disease Clinic

    C. Marshall, W. Aamodt, J. Klapper, P. Cinicola, N. Kleinberg, A. Lasker (Philadelphia, USA)

    Objective: To better understand and describe the impact of providing spiritual care, in the form of a chaplain service, to patients being seen in a…
  • « Previous Page
  • 1
  • …
  • 126
  • 127
  • 128
  • 129
  • 130
  • …
  • 1554
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Screening and Treatment of Depression in Parkinson’s Disease within Movement Disorders Centers: A Quality Improvement Initiative
  • An atypical and interesting feature of Parkinson´s disease
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley